3,3 ¶-Diindolylmethane (DIM) is a stable condensation product of indole-3-carbanol, a potential breast cancer chemoprevention agent. Human breast cancer cell lines were studied to better understand its mechanisms.
Introduction
Breast cancer remains the second most common and lethal malignancy in women worldwide. The accepted prevention agent in breast cancer is tamoxifen, which is limited to a f45% reduction in the risk of breast cancer (1) . Because its mechanism of action is dependent on the presence of the estrogen receptor (ER), it does not appear to influence treatment of cancers that are ER negative. Other hormonal agents under clinical investigation (e.g., aromatase inhibitors) will likely be limited in their efficacy in preventing ER-negative tumors, because their mechanism of action is the inhibition of peripheral conversion of estrogen. In advanced metastatic breast cancer, response duration and survival prolongation are measured in months despite many available chemotherapies (2) . Newer hormonal agents, such as aromatase inhibitors, yield only a 15% to 20% response rate with major cross-resistance with tamoxifen (3) . Thus, there is a clear need to develop other prevention or treatment approaches with low side effect profiles.
Epidemiologic data suggest that, in Asian regions, diets rich in cruciferous vegetables are associated with a markedly reduced incidence of breast cancer (4) . Studies have shown that cruciferous vegetables, particularly cabbage, broccoli, and Brussels sprouts, are a rich source of many phytochemicals, including indole derivatives, such as indole-3-carbanol (I3C). I3C is an effective oral chemopreventive agent that can inhibit mammary tumors in carcinogen-induced rat models and in a v-H-ras transgenic mouse model (5, 6) . I3C, in a low pH environment, is easily converted to its dimeric product 3,3 ¶-diindolylmethane (DIM). DIM may be responsible for many of the biological effects attributed to I3C. For example, in a sensitive trout hepatocarcinogenesis model, DIM, but not I3C, was chemopreventive when both molecules were administered by injection (7) . DIM also markedly prevented further growth of established (100-200 mm 3 ) 7,12-dimethylbenz[a]anthracene-induced breast tumors in rats (8) . Because of the potential application of DIM in breast cancer prevention, we sought to better understand its mechanisms of action.
DIM not only inhibits cell growth and DNA synthesis but also induces apoptosis in MCF-7 and T47D ER-positive breast cancer cells (8, 9) . Inhibition of DNA synthesis and induction of apoptosis in ER-negative MDA-MB-231 breast cancer cells by DIM has also been shown (10) . However, the mechanisms of these effects are only partly understood. Although I3C has been shown to induce p21 and p27 in breast cancer cells (11) , this has not been confirmed for DIM. Recently, we have reported that DIM can inhibit Akt activation in MCF10A breast cancer cells (12) . Akt is a reasonable molecular target in breast cancer as it is activated in the majority of breast cancer cell lines and tumors (13) .
Based on the above information, we hypothesized that the blockade of Akt signaling and induction of p27 kip by DIM are linked events, because Akt can phosphorylate and repress the forkhead family of transcription factors (14) , which are known to transactivate the p27 kip promoter (15) . Moreover, it has been recently reported that Akt is one of several kinases that can directly phosphorylate p27 kip at multiple sites, resulting in the nuclear export of p27 kip (16) , its cytoplasmic localization through 14-3-3 binding (17), or its degradation by the ubiquitin-ligase proteozyme complex (18) . In this report, we examined if DIM could reciprocally inhibit Akt and induce p27 kip and thus explored potential mechanisms. BT-20 and BT-474 breast cancer cells were selected for further study because of the limited information on the effect of DIM on breast cancer cells, particularly those with overexpression of Her-2 or activated Akt.
Materials and Methods
Cell Lines and Culture Methods MCF-7, T47D, BT-20, and BT-474 cells were obtained from American Type Culture Collection and cultured according to recommended conditions. For all experiments, cells were used with 20 or fewer passages after being received from American Type Culture Collection. MCF-7 cells were cultured in DMEM, whereas the others were cultured in RPMI. All media were supplemented with 10% FCS, 2 mmol/L glutamine, 100 units/mL penicillin, and 100 Ag/mL streptomycin (all culture reagents from Invitrogen).
Reagents DIM (LKT) from one stock was used for all experiments, diluted in DMSO at 100 mmol/L stocks frozen at À80jC for up to 6 months, conditions that maintained stability for up to 6 months according to the supplier.
MTT Growth Assay Growth inhibition by DIM was determined by a MTT assay. Subconfluent cells were trypsinized and plated in 96-well culture plates at 5,000 cells in 200 AL complete medium added to a quadruplet set of wells for each DIM concentration. The next day (day 0), complete medium was changed with DIM at the desired final concentrations. A baseline plate was assayed on day 0. After 5 days of incubation, cell mass was measured by adding 40 AL MTT at 5 mg/mL (Sigma) per well followed by incubation at 37jC for 2 h. Wells were aspirated, 100 AL isopropanol was added, and plates were gently shaken for 30 min.
Absorption at 595 nm was measured on an Ultra plate reader (Tecan). After the background signal of mediumcontaining blank wells was subtracted from all wells, values were normalized to the day 0 average values, and the relative growth inhibition by DIM wells was calculated by dividing the values from control wells without DIM. Relative growth mean and SD was graphed versus log DIM concentration, and IC 50 was calculated by a sigmoidal doseresponse curve with Prism software (GraphPad). The IC 50 values presented are the average of at least two independent experiments.
Apoptosis Assay Nucleosomal DNA was assayed with the ELISA PLUS (Roche) kit using the provided protocol with minor modifications. BT-20 or BT-474 cells were plated in duplicate wells at 2.0 Â 10 5 per well in six-well dishes and cultured overnight. DIM was added at 0 and 50 Amol/L (BT-474) or 100 Amol/L (BT-20). At 24, 48, and 72 h, both floating and trypsinized cells were collected and washed and both viable and dead cells were counted by trypan staining. Fifty-thousand cells (live or dead) were extracted with 500 AL incubation buffer, and after pelleting, the supernatant was saved at À20jC. A sample of 100 AL of each extract (diluted 1:10 in incubation buffer) was processed per protocol. Signal was assayed for absorption at 405 nm in the Ultra plate reader. The mean and SD from at least two independent experiments (n of at least 4) were plotted with Prism software.
Immunoblotting Cells were cultured at 5 Â 10 6 in 150-mm dishes to 50% to 60% confluence. Total cell extract was prepared from scraped cells as described previously (19) with minor modifications. The lysis buffer included 1 mmol/L phenylmethylsulfonyl fluoride, 1 Ag/mL pepstatin, and 4% (v/v) protease inhibitor cocktail (Roche). Protein concentration was measured with the BCA kit (Pierce) and 50 Ag were electrophoresed in 10% to 16% denaturing acrylamide gels and transferred to Optiran reinforced nitrocellulose membranes (Schleicher & Schuell). Membranes were blocked in PBS with 5% milk and 0.1% Tween 20 followed by incubation with primary antibodies in blocking buffer (or in PBS with 5% bovine serum albumin and 0.1% Tween 20 for anti-phospho-substrate antibodies) overnight at 4jC. Primary antibodies were anti-Her-2 at 1:40 (OP-15; Calbiochem), anti-Akt1 at 1:1,000 (9272; Cell Signaling), antiphospho-Akt at 1:1000 (9271; Cell Signaling), anti-p27 kip at 1:1,000 (sc-528; Santa Cruz), and anti-actin at 1:5,000 (A5441; Sigma). Appropriate secondary horseradish peroxidaselinked antibodies (Amersham or Bio-Rad) were used. Membranes were developed with SuperSignal chemiluminescence (Pierce) and images captured on film, scanned as Adobe files, and formatted in PowerPoint. Densitometry was done on a Gel Doc 1000 (Bio-Rad), and signals were normalized to actin expression and displayed in bar graphs. Values from at least three different gels from two or more independent experiments were included in the analysis.
For testing effects of DIM on protein expression, BT-20 and BT-474 cells were cultured to subconfluence. On day 0, medium was exchanged to include DIM at the final concentration of 0 (DMSO control), 50 and 100 Amol/L for BT-20, or 0 (DMSO control), 25, and 50 Amol/L for BT-474. Total cell extract was harvested 24, 48, and 72 h later and probed and analyzed as above.
Real-time Reverse Transcription-PCR Analysis of p27 kip Expression after DIM Treatment BT-20 or BT-474 cells were plated overnight and treated with DIM at the indicated concentrations and harvested 6 and 24 h after exposure. Total RNA was harvested with Trizol (Invitrogen). Total RNA (1 Ag) was processed for first-strand cDNA synthesis using TaqMan reverse transcription (RT) reagents kit (Applied Biosystems) in a total volume of 50 AL, including 6.25 units MultiScribe reverse transcriptase and 25 pmol random hexamers. The RT reaction was done at 25jC for 10 min followed by 48jC for 30 min and 95jC for 5 min. The primers used in the PCR were the p27 kip and glyceraldehyde-3-phosphate dehydrogenase sequences validated previously by Yakes et al. (20) . The primers were checked by verifying the expected product size in a virtual PCR analysis and primer concentration was optimized to avoid primer dimer formation. Also, dissociation curves were checked to confirm specific amplification. Triplicate real-time PCR amplications for each primer set were undertaken in a MX4000 Multiplex QPCR System (Stratagene) using 2Â SYBR Green PCR Master Mix (Applied Biosystems). One microliter of the RT reaction was used in a total volume of 25 AL PCR mix. The thermal profile for PCR was 95jC Â 10 min followed by 40 cycles of 94jC Â 15 s and then 60jC Â 1 min. The threshold cycle of each amplification was determined and used to calculate the quantity of RNA based on a serially diluted standard curve of the time 0 control sample. The p27 kip product was adjusted to that of general transcription by dividing the quantity of p27 kip RNA by that of glyceraldehyde-3-phosphate dehydrogenase for each sample. Finally, the relative p27 kip product of each sample was normalized by dividing by the relative p27 kip product at time 0 (control). The entire experiment was repeated and relative p27 kip signals were plotted as a bar graph showing the means and SDs.
Protein Half-life BT-20 or BT-474 cells were plated at 1.0 Â 10 6 per 60-mm dishes and cultured overnight. DMSO (control) or DIM was added at a final concentration of 100 Amol/L (BT-20) or 50 Amol/L (BT-474), and the cells were cultured for 24 h. A set of control plates was harvested just before DMSO or DIM was added to study plates. Twenty-four hours after DIM exposure, 25 Ag/mL cyclohexamide (C-7698; Sigma) was added, and plates were harvested at 0, 1, 2, 4, 6, 8, 12, 24, and 30 h afterward. Total cell extract was harvested and probed by immunoblotting for p27 kip or actin as above. Densitometry of film acquired images was done and normalized to expression at time 0 h after cyclohexamide addition. Half-life was calculated based on appropriate curve fitting algorithms in Prism.
Immunofluorescence Confocal Microscopy BT-20 or BT-474 cells were cultured overnight on coverslips in six-well dishes at 1.5 Â 10 5 cells per well. The next day, medium was replaced with DIM at 50 Amol/L for BT-474 and 100 Amol/L BT-20 cells, and cells were cultured for 48 h. Cells were fixed with 10% formalin for 10 min, washed with PBS, air dried, and stored at 4jC for less than 1 week. After a PBS wash, coverslips were treated with 0.5% Triton X-100 in PBS for 10 min then incubated at 37jC for 2.5 h with anti-p27 kip antibody at 1 Ag/mL (K25020; BD Transduction Labs) or control murine IgG at 0.5 Ag/mL (12-371; Upstate Biotechnology) in PBS with 0.05% Triton X-100. After three washes in the same buffer, incubation was done with FITC-conjugated anti-mouse antibody at 1:100 (A11029; Molecular Probes) along with 0.1 Ag/mL 4 ¶,6-diamidine-2 ¶-phenylindole (Sigma) in the same buffer for 1 h at 37jC. After three washes and air drying, coverslips were mounted with Antifade (Molecular Probes). Images were captured on a Zeiss 310 laser scanning inverted confocal microscope system, using a 63 Â 1.2 objective, and 488 and 364 nm laser wavelengths to detect the FITC and 4 ¶,6-diamidine-2 ¶-phenylindole stains, respectively. Images were converted to Adobe Photoshop files and then formatted into PowerPoint images.
Cytoplasmic-Nuclear Fractionation of Cells BT-474 or BT-20 cells were plated at 6 Â 10 6 per 150-mm dish and cultured until 50% to 60% confluent. Ag/mL aprotinin, 20 Ag/mL leupeptin, 20 Ag/mL pepstatin] with 0.25% NP-40, and incubated for 30 to 40 min on ice, until lysis of the cytoplasmic membrane to at least 95% was confirmed by trypan staining. Nuclei were pelleted by spinning at 600 Â g for 6 min at 4jC. Supernatant was removed and saved at -80jC as the cytoplasmic fraction. Nuclei were pelleted again to remove contaminating cytoplasmic debris. The nuclear pellet was gently resuspended and washed twice with 500 AL SL buffer without NP-40 (SL minus NP). The nuclei were gently resuspended in 500 AL SL minus NP buffer then syringed gently through a 21-gauge needle three times. Nuclei were pelleted again, resuspended in SL minus NP buffer, and layered onto a 0.85 mol/L sucrose cushion buffer and centrifuged at 16,000 Â g for 15 min at 4jC. The pelleted nuclei were washed again with SL minus NP buffer then extracted in high-salt buffer and pelleted (21) . This supernatant (nuclear extract) was saved and stored at -80jC. Protein concentration of cytoplasmic and nuclear fractions was measured as above, and 50 Ag of each sample were analyzed by immunoblotting. Primary antibodies used were anti-p27 kip at 1:1,000 (SC-528; Santa Cruz), anti-MEK at 1:400 (SC-219; Santa Cruz), and anti-retinoblastoma protein at 1:200 (14001A; PharMingen) proteins. Images were formatted and densitometry was done as other immunoblots. The relative expression of nuclear and cytoplasmic p27 kip was expressed by dividing the nuclear or cytoplasmic signals by either retinoblastoma or MEK band signals, respectively, and the relative ratio of nuclear to cytoplasmic expression calculated and bar graphed.
Immunoprecipitation of p27 kip in BT-20 Cells Cells were seeded at 2 Â 10 6 on 100-mm dishes and cultured for 48 h. DIM was added at 0, 50, and 100 Amol/L and incubated for 24 h. Immunoblots were developed with appropriate secondary antibodies. Relevant bands were imaged on film and analyzed by densitometry. To determine the relative amount of phospho-p27 kip or p27 kip associated with 14-3-3, the signals from relevant phospho-Thr 187 or 14-3-3 bands were divided by the total p27 kip detected.
Results

Constitutive Expression of Her-2 and Akt in Breast Cell Lines
The baseline expression of Her-2 was determined in a panel of human breast cancer cell lines that included BT-20, BT-474, MCF-7, and T47D. The assays included the expression of Her-2 activated downstream signaling proteins (phospho-Akt) and p27 proteins that are transcriptionally regulated by Akt. All four cell lines expressed high levels of Akt, but only BT-20 expressed high level of phospho-Akt (Fig. 1A) . BT-474 and T47D expressed high and modest levels of Her-2, respectively. However, MCF-7 and BT-20 showed low level of Her-2 (Fig. 1A) . The results showed that the Her-2, Akt, and p27 were frequently but differentially dysregulated in the different human breast cancer cell lines.
DIM Inhibits Growth and Induces Apoptosis in Multiple Breast Cancer Cell Lines
The effect of DIM on cell growth of breast cancer cells is depicted in Table 1 . We found that the IC 50 after 4 days of DIM exposure for all the cell lines appears to be in a similar range of 30 to 60 Amol/L regardless of Her-2, Akt, or ER status. Because DIM has been reported to modulate Akt, and in view of the observed increased activation of Akt in BT-20 and BT-474 cells, we sought to further define the effects of DIM in these cells. This inhibition of cell proliferation could be due to cell cycle arrest, resulting in the inhibition of cell growth. Alternatively, the inhibition of cell growth could be attributed to the induction of apoptotic cell death induced by DIM in breast cancer cells. Therefore, we investigated whether DIM could induce apoptosis in these cells. The effects of DIM on apoptosis are shown in Fig. 1B . In BT-474 cells, the induction of apoptosis occurred at 24 h and the decrease in viability by 48 h, whereas the same events occurred about 24 h later, respectively, in BT-20 cells. 
Effect of DIM on Akt and p27 kip over Time in BT-20 and BT-474 Cell Lines
Because others have reported that I3C induces p21 and p27 kip in MCF-7 cells after about 60 h of exposure (11), we studied the time course of effects in both cell lines. As seen in Fig (Fig. 2B) . Moreover, this induction of p27 kip appeared to occur at or before significant loss of cell viability or apoptosis (Fig. 1B) . Thus, p27 kip induction preceded these events. DIM at 25 or 50 Amol/L did not inhibit Akt expression or activation in BT-474 cells (data not shown).
DIM Induces p27 kip Expression by Both Transcription and Prolonging Protein Half-life
In both BT-474 and BT-20 cells, DIM induced p27 kip transcript expression as measured by real-time RT-PCR (Fig. 3A) . This occurred as early as 6 h after DIM exposure, at 50 and 100 Amol/L, respectively. Because ubiquitinationdependent degradation of p27 kip is dependent on phosphorylation of p27 kip by cyclin-dependent kinases (cdk; ref. 22) , and because I3C is known to inhibit cdk6 (11), we studied if DIM prolonged the half-life of p27 kip protein. As shown in Fig. 3B , BT-20 cells exposed to 100 Amol/L DIM for 24 h significantly prolong p27 kip half-life from 3.9 to 27 h. However, in BT-474 cells, 50 Amol/L DIM did not prolong the half-life compared with control DMSO, with half-lives of 8.8 and 8.5 h, respectively (data not shown), indicating that this effect is not universal.
DIM Induces Nuclear Translocation of p27 kip
Recent work by others has shown that p27 kip expression and localization may also be modulated by its phosphorylation by several serine-threonine kinases, including Akt and cdk2 (18) . Confocal experiments showed that DIM at 50 Amol/L treatment for 48 h significantly induced nuclear expression of p27 kip in BT-474 cells (Fig. 4A) . A similar increase in nuclear p27 kip was also detected by confocal microscopy in the nuclei of BT-20 cells exposed to 100 Amol/L DIM (data not shown). This was confirmed by cell fractionation studies in the BT-474 cells (Fig. 4B) (Fig. 5B ). This change in p27 kip status is consistent with a mechanism in which DIM inhibits cdk-dependent phosphorylation of this site, therefore restricting ubiquitindependent proteolysis, and promoting prolongation of its protein half-life. In addition, probing for the 14-3-3 protein showed that there was a relative decrease in the amount of p27 kip associated with 14-3-3 (Fig. 5B) . Because 14-3-3 can sequester p27 kip to the cytoplasm, one mechanism of its nuclear localization may be the loss of association with 14-3-3.
Discussion
In this report, we show in human breast cancer cells that DIM induces p27 kip before the induction of apoptosis and cell death. Therefore, the modulation of p27 kip may play a role in its mechanisms of action. We show that the induction of p27 kip may occur by increasing transcription in both BT-20 and BT-474 cell lines and by the prolongation of p27 kip half-life in BT-20 cells. Moreover, we show, for the first time, that DIM induces nuclear localization of p27 kip , an event that is relevant to its primary function in inhibiting cdks and inducing growth arrest. The induction of p27 kip may also directly trigger apoptosis in human breast cancer cell lines and other cell lines, independent of the inhibition of Akt signaling, as evidenced by results from p27 kip gene transfer studies (23, 24) . The mechanisms of modulation of p27 kip are relatively complex, occurring at transcriptional, translational, and post-translational levels. Therefore, we explored potential mechanisms. First, we show that DIM induces its transcription as early as 6 h after exposure (Fig. 3A) . Because Akt activation is inhibited by DIM, the induction of p27 kip is consistent with a model in which DIM reverses the Aktdependent repression of the forkhead family of transcription factors (14, 25) . These activated transcription factors are known to specifically transactivate the p27 kip promoter (15) . Ectopic expression of forkhead-type transcription factors in a variety of cell lines, including human colon carcinoma cells, has been shown to consistently trigger p27 kip expression and cell cycle arrest (26) . Moreover, the effects of DIM are consistent with those of inhibitors of phosphatidylinositol-3-kinase, such as LY294002 and Wortmannin, which have been shown to inhibit Akt activation, activate the forkhead member, AFX, and induce expression of p27 kip (27) . DIM may activate the p27 kip promoter through other control elements in its structure, such as those that bind Sp1, nuclear factor-nB, CRE, and Myb related elements (28) . Sp1 may be involved, because I3C can inhibit cdk6 promoter activity, and this is dependent on a Sp1-binding site in MCF-7 breast cancer cells (29) . Modulation of nuclear factor-nB may also be relevant, because DIM can inhibit nuclear factor-nB activation in breast cancer cells (12) . Because the induction of p27 kip transcription and expression appears to precede inhibition of Akt in BT-20 cells, and inhibition of Akt was not observed in BT-474 cells, transcription factors other than the forkhead family are likely to be involved.
Other important mechanisms of p27 kip induction by DIM described in this report are related to its post-translational processing. For example, DIM significantly prolonged its protein half-life in BT-20 cells. Because it has been shown that p27
kip has several sites of phosphorylation that control its proteolytic fate, we examined the status of phosphorylation at Thr 187 , which when phosphorylated facilitates the binding of the ubiquitin-ligase complex, ubiquitination, and proteolysis (18) . DIM treatment caused a relative decrease in phospho-Thr 187 in BT-20 cells as early as 24 h (Fig. 5) , in the same timeframe as the observed prolongation of p27 kip half-life. Therefore, our data support a mechanism in BT-20 cells that operates through blockade of Thr 187 phosphorylation, thus preventing its ubiquitination and degradation. The exact kinase responsible for phosphorylation at this site targeted by DIM remains to be clarified. Because Fujita et al. reported that Akt can phosphorylate this site (17) , our observation on the induction of p27 kip protein expression at approximately the same time as a decrease in Akt protein expression (Fig. 2B) supports a mechanism in which DIM inhibits Akt-dependent phosphorylation of p27 kip . Targeting of cdk2 or cdk6 is also possible, because cdk2 and cdk6 are known to phosphorylate Thr 187 (17, 30) , and Cover et al. has found that I3C can inhibit cdk6 expression and activity in breast cancer cells (11) . Although mitogen-activated protein kinase has also been reported to phosphorylate Thr 187 (31), we observed that DIM does not alter expression of phosphoErk, suggesting that DIM does not inhibit the mitogenactivated protein kinase pathway (data not shown). For BT-474 cells, prolongation of protein half-life was not found, suggesting other mechanisms of induction. This is consistent with the observed lack of inhibition of Akt activation in BT-474 cells at the doses tested.
We also show for the first time that DIM induces nuclear localization of p27 kip in human breast cancer cells. This is shown by both confocal microscopy and cell fractionation experiments in both BT-474 and BT-20 cells (Fig. 4) . This is kip is in BT-20 cells after exposure to DIM for 24 h. BT-20 cells were exposed to DIM at the indicated concentrations followed by immunoprecipitation of p27 kip from cell extracts. Top, immunoblots for p27 kip , phospho-Thr 187 -p27 kip (pT187-p27 ), and the 14-3-3 protein; bottom, densitometry analysis of immunoblots indicates induction of p27 kip (left ), a relative decrease in the fraction of p27 kip that is phosphorylated at Thr 187 (middle), and relative decrease in the amount of 14-3-3 associated with p27 kip (right ). *, P < 0.01, compared with the control. kip binding and inhibition in the nucleus. This is also consistent with the observation that in primary breast cancer tissues p27 kip is frequently abnormally localized to the cytoplasm (32) . Therefore, DIM may inhibit breast cancer growth by inducing nuclear localization of p27 kip , which then initiates G 0 -G 1 cell cycle arrest, consistent with the effects of I3C (11, 33 (17) . Our data show that DIM causes a relative decrease in 14-3-3 associated with p27 kip (Fig. 5) , consistent with the increase in nuclear localization observed. Aktdependent phosphorylation of Thr 157 is another mechanism that impairs nuclear import of p27 kip and G 0 -G 1 arrest in human breast cancer cells and tumors (32, 34) . Indirect modulation of this phosphorylation site by DIM may also contribute to nuclear localization. It is important to mention that DIM induced p27 expression, which could be dependent on cell type. It has been reported that DIM do not induce p27 expression in MDA-MB-231 and MCF-7 breast cancer cell lines (10, 35) . Our microarray data also showed that p27 expression was not changed in MDA-MB-231 breast cancer cells treated with DIM. 3 Moreover, we found that DIM also did not induce p27 expression in MCF10CA1a breast cancer cell lines (data not shown).
The findings that DIM inhibits Akt and induces p27 kip in breast cancer cells should stimulate further investigation, because human breast cancers often overexpress activated Akt (36), underexpress p27 kip (37) , or have cytoplasmic localization of p27 kip (32) . The underexpression of p27 kip is associated with advance stage and appears to be an important independent negative survival factor (37, 38) . Both Akt inhibition and the induction of p27 kip may independently contribute to stimulating apoptosis in breast cancer cells (39, 40) . The effects of DIM occur even in Her-2-or Akt-overexpressing breast cancer cells, such as BT-20 and BT-474. Inducing p27 kip may be a particularly relevant effect of DIM in Her-2-overexpressing cells based on our results, because Her-2 has been shown to repress p27 kip expression and nuclear localization (19, 20) , and inhibition of Her-2 signaling induces p27 kip (20, 21) . It is possible that DIM may also inhibit signaling at levels upstream to Akt, such as at the Her-2 receptor, because we have reported previously that I3C can repress epidermal growth factor receptor expression and activation in prostate cancer cells (41) .
In summary, our data showed that DIM can inhibit growth and survival of breast cancer cells in spite of Her-2 or Akt overexpression or in the absence of ER. Furthermore, we propose a model in which DIM induces apoptosis and cell cycle arrest by several mechanisms, including the inhibition of Akt, induction of p27 kip expression, and nuclear localization of p27 kip . Additional in vitro and in vivo studies are needed to further define the mechanisms of action and to assess the potential role of DIM in the prevention of human breast cancer.
